Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 9, 2022
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
the
dominant
cause
of
worldwide.
steatohepatitis
(NASH),
a
more
aggressive
presentation
NAFLD,
characterized
by
severe
hepatocellular
injury,
inflammation,
and
fibrosis.
Chronic
inflammation
heightened
immune
cell
activity
have
emerged
as
hallmark
features
NASH
key
drivers
fibrosis
through
activation
hepatic
stellate
cells
(HSCs).
Recent
advances
in
our
understanding
molecular
cellular
pathways
highlighted
extensive
crosstalk
between
HSCs
populations
that
strongly
influences
activity.
Here,
we
review
these
findings,
emphasizing
roles
immunity
cell-cell
interactions,
exciting
areas
for
future
investigation.
Science Immunology,
Journal Year:
2023,
Volume and Issue:
8(82)
Published: April 7, 2023
Macrophages
are
central
orchestrators
of
the
tissue
response
to
injury,
with
distinct
macrophage
activation
states
playing
key
roles
in
fibrosis
progression
and
resolution.
Identifying
populations
found
human
fibrotic
tissues
could
lead
new
treatments
for
fibrosis.
Here,
we
used
liver
lung
single-cell
RNA
sequencing
datasets
identify
a
subset
CD9+TREM2+
macrophages
that
express
SPP1,
GPNMB,
FABP5,
CD63.
In
both
murine
hepatic
pulmonary
fibrosis,
these
were
enriched
at
outside
edges
scarring
adjacent
activated
mesenchymal
cells.
Neutrophils
expressing
MMP9,
which
participates
TGF-β1,
type
3
cytokines
GM-CSF
IL-17A
coclustered
macrophages.
vitro,
GM-CSF,
IL-17A,
TGF-β1
drive
differentiation
monocytes
into
scar-associated
markers.
Such
differentiated
cells
degrade
collagen
IV
but
not
I
promote
TGF-β1-induced
deposition
by
models
blocking
or
reduced
expansion
Our
work
identifies
highly
specific
population
assign
profibrotic
role
across
species
tissues.
It
further
provides
strategy
unbiased
discovery,
triage,
preclinical
validation
therapeutic
targets
based
on
this
fibrogenic
population.
Molecular Neurodegeneration,
Journal Year:
2022,
Volume and Issue:
17(1)
Published: June 3, 2022
Triggering
receptor
expressed
on
myeloid
cells
2
(TREM2)
is
a
single-pass
transmembrane
immune
that
mainly
microglia
in
the
brain
and
macrophages
periphery.
Recent
studies
have
identified
TREM2
as
risk
factor
for
Alzheimer's
disease
(AD).
Increasing
evidence
has
shown
can
affect
lipid
metabolism
both
central
nervous
system
(CNS)
In
CNS,
affects
of
cholesterol,
myelin,
phospholipids
promotes
transition
into
disease-associated
phenotype.
periphery,
influences
by
regulating
onset
progression
obesity
its
complications,
such
hypercholesterolemia,
atherosclerosis,
nonalcoholic
fatty
liver
disease.
All
these
altered
processes
could
influence
pathogenesis
AD
through
several
means,
including
affecting
inflammation,
insulin
resistance,
pathologies.
Herein,
we
will
discuss
potential
pathway
mediates
to
CNS
Moreover,
possibility
may
be
key
links
peripheral
under
conditions,
AD.
This
link
due
impacts
integrity
blood-brain
barrier,
introduce
pathways
which
barrier.
role
lipids
TREM2-associated
treatments
We
propose
some
therapies
targeting
prospect
limitations
therapies.
Molecular Neurodegeneration,
Journal Year:
2022,
Volume and Issue:
17(1)
Published: Dec. 23, 2022
Abstract
Microglia
are
central
players
in
brain
innate
immunity
and
have
been
the
subject
of
extensive
research
Alzheimer’s
disease
(AD).
In
this
review,
we
aim
to
summarize
genetic
functional
discoveries
that
advanced
our
understanding
microglia
reactivity
AD
pathology.
Given
heightened
risk
posed
by
rare
variants
microglial
triggering
receptor
expressed
on
myeloid
cells
2
(TREM2),
will
focus
studies
addressing
impact
responses
amyloid
plaques,
tauopathy
demyelination
pathologies
mouse
human.
Finally,
discuss
implications
recent
TREM2
biology
potential
therapeutic
strategies
for
AD.
Gastroenterology,
Journal Year:
2022,
Volume and Issue:
162(7), P. 1858 - 1875.e2
Published: March 3, 2022
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
a
chronic
condition
affecting
one
quarter
of
the
global
population.
Although
primarily
linked
to
obesity
and
metabolic
syndrome,
undernutrition
altered
(dysbiotic)
gut
microbiome
influence
NAFLD
progression.
Both
prevalence
are
predicted
considerably
increase,
but
how
undernourished
contributes
hepatic
pathophysiology
remains
far
less
studied.
Here,
we
present
conditions
with
features,
including
kwashiorkor
micronutrient
deficiency.
We
then
review
microbiota-liver
axis,
highlighting
key
pathways
progression
within
both
overnutrition
undernutrition.
To
conclude,
identify
challenges
collaborative
possibilities
emerging
multiomic
research
addressing
pathology
treatment
NAFLD.
Gastroenterology,
Journal Year:
2023,
Volume and Issue:
165(1), P. 201 - 217
Published: April 5, 2023
Background
&
AimsNonalcoholic
steatohepatitis
(NASH)
is
characterized
by
steatosis,
lobular
inflammation,
hepatocyte
ballooning
degeneration,
and
fibrosis,
all
of
which
increase
the
risk
progression
to
end-stage
liver
disease.
Osteopontin
(OPN,
SPP1)
plays
an
important
role
in
macrophage
(MF)
biology,
but
whether
MF-derived
OPN
affects
NASH
unknown.MethodsWe
analyzed
publicly
available
transcriptomic
datasets
from
patients
with
NASH,
used
mice
conditional
overexpression
or
ablation
Spp1
myeloid
cells
MFs,
fed
them
a
high-fat,
fructose,
cholesterol
diet
mimicking
Western
diet,
induce
NASH.ResultsThis
study
demonstrated
that
MFs
high
expression
SPP1
are
enriched
nonalcoholic
fatty
disease
(NAFLD),
show
metabolic
not
pro-inflammatory
properties.
Conditional
knockin
(Spp1KI
Mye)
hepatic
macrophages
LvMF)
conferred
protection,
whereas
knockout
(Spp1ΔMye)
worsened
NASH.
The
protective
effect
was
mediated
induction
arginase-2
(ARG2),
enhanced
acid
oxidation
(FAO)
hepatocytes.
Induction
ARG2
stemmed
production
oncostatin-M
(OSM)
Spp1KI
Mye
mice.
OSM
activated
STAT3
signaling,
upregulated
ARG2.
In
addition
effects,
also
protected
through
sex-specific
extrahepatic
mechanisms.ConclusionMF-derived
protects
upregulating
OSM,
increases
signaling.
Further,
ARG2-mediated
FAO
reduces
steatosis.
Therefore,
enhancing
OPN–OSM–ARG2
crosstalk
between
hepatocytes
may
be
beneficial
for
Nonalcoholic
unknown.
We
This
mechanisms.